Pacira BioSciences (PCRX) Return on Equity [ROE] (2011 - 2026)
Pacira BioSciences (PCRX) recorded Return on Equity [ROE] of 2.21% in Q2 2026, up 18.59 percentage points from -16.38% a year earlier and up 1.45 percentage points from the prior quarter.
Powered by 
Analysis
Pacira BioSciences (PCRX) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Pacira BioSciences reported Return on Equity [ROE] of 0.96%, up 13.04 percentage points from FY2024.
- Annual Return on Equity [ROE] has a five-year change of -28.91 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -12.08% in FY2024 (-17.18 pp), 5.10% in FY2023 (+2.99 pp), 2.11% in FY2022 (-4.11 pp) and 6.22% in FY2021 (-23.64 pp).
- Quarterly Return on Equity [ROE] has ranged from -16.38% in Q2 2025 to 8.76% in Q3 2021 over the past five years.
- On a year-over-year basis, Return on Equity [ROE] has increased for four consecutive quarters, with an average year-over-year change of -1.76 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 18.59 percentage points in Q2 2026, against a drop of 23.56 percentage points in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 0.76% (Q1 2026), 0.99% (Q4 2025) and 2.89% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Pacira BioSciences | 1.46 Bn | 468.61 Mn | 139.42 Mn | 5.45% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.45% |
| Jun 30, 2026 | 2.21% |
| Mar 31, 2026 | 0.76% |
| Dec 31, 2025 | 0.99% |
| Sep 30, 2025 | 2.89% |
| Jun 30, 2025 | -16.38% |
| Mar 31, 2025 | -13.16% |
| Dec 31, 2024 | -13.03% |
| Sep 30, 2024 | -11.14% |
| Jun 30, 2024 | 7.18% |
| Mar 31, 2024 | 8.00% |
| Dec 31, 2023 | 4.93% |
| Sep 30, 2023 | 0.85% |
| Jun 30, 2023 | -0.58% |
| Mar 31, 2023 | -1.36% |
| Dec 31, 2022 | 2.06% |
| Sep 30, 2022 | 2.74% |
| Jun 30, 2022 | 5.35% |
| Mar 31, 2022 | 5.34% |
| Dec 31, 2021 | 5.79% |
API Access
Pacira BioSciences Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();